SM
SG3 Management’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Hold |
0
| – | – | – | 316 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 567 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 552 |
|
|
2021
Q3 | – | Sell |
-8,500
| Closed | -$827K | – | 515 |
|
|
2021
Q2 | $827K | Sell |
8,500
-16,500
| -66% | -$1.61M | 0.03% | 73 |
|
|
2021
Q1 | $2.43M | Buy |
+25,000
| New | +$2.43M | 0.06% | 24 |
|
|
2020
Q4 | – | Sell |
-7,000
| Closed | -$673K | – | 513 |
|
|
2020
Q3 | $673K | Buy |
7,000
+5,000
| +250% | +$481K | 0.02% | 79 |
|
|
2020
Q2 | $244K | Buy |
+2,000
| New | +$244K | 0.02% | 105 |
|